Stimulation with TLR9 agonist, CpG, induced a heightened intracellular expression of both IL-1β and TNFα in CD14+ CD16+ monocyte subsets, where their respective cytokine expression was similar for both healthy and RA patients (Fig. 6a). The gene discussed is TLR9; the disease is rheumatoid arthritis.